ArticleWorld journal of urology2026
Transvaginal vesicovaginal fistula repair-high success with low morbidity despite radiation or prior repair.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVesicovaginal fistula (VVF) surgical repair can be done transvaginal or transabdominal, laparoscopic, or robotic. Controversy exists regarding optimal approach, especially in those who have had prior radiation treatment, and those with prior VVF repair. We aimed to review our large fistula cohort to determine the success of transvaginal VVF repair.
methodsBetween 1995 and 2022, 83 women with VVF underwent transvaginal VVF repair. All data were captured in a prospective database. Transvaginal approach involved multi-layer closure with monofilament absorbable sutures and local flap interposition. Success was cystogram evidence of fistula closure and freedom from re-operation.
resultsMean patient age was 47 (median 49, range 24–81). 96% had previous pelvic surgery, 24% had prior pelvic malignancies, and 11% had pelvic radiation. Etiology was hysterectomy (76%), other surgery (12%), childbirth (8%), and radiation (4%). Mean time from fistula to repair was 14.6 months (median 7, range 2–276). 31% had previous failed repair. 99% were successfully closed after one transvaginal repair with a follow-up mean of 17 months (median 9, range 1–142). One patient had fistula recurrence, and had previously been irradiated. No difference in outcome was seen with either post-operative suprapubic or urethral catheter. No significant perioperative morbidity was encountered. 55% had a one day hospital stay.
conclusionsTransvaginal VVF repair is an efficacious treatment for VVF. Due to its relative lack of morbidity and low costs, vaginal repair can be considered first as a surgical option and can be considered in patients who have undergone pelvic irradiation or in those with prior unsuccessful VVF repair.
Indexed as
Identifiers
41642442What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.